These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31091375)

  • 1. Muco-Obstructive Lung Diseases.
    Boucher RC
    N Engl J Med; 2019 May; 380(20):1941-1953. PubMed ID: 31091375
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB; Ilowite JS
    Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.
    Kellett F; Robert NM
    Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravital microscopic optical coherence tomography imaging to assess mucus-mobilizing interventions for muco-obstructive lung disease in mice.
    Pieper M; Schulz-Hildebrandt H; Mall MA; Hüttmann G; König P
    Am J Physiol Lung Cell Mol Physiol; 2020 Mar; 318(3):L518-L524. PubMed ID: 31994896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of nebulized hypertonic saline for muco-obstructive lung diseases: a systematic review and meta-analysis with trial sequential analysis.
    Zhang Y; Song A; Liu J; Dai J; Lin J
    J Investig Med; 2021 Mar; 69(3):742-748. PubMed ID: 33272932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immotile-cilia syndrome compared to other obstructive lung diseases: a clue to their pathogenesis.
    Mossberg B; Camner P; Afzelius BA
    Eur J Respir Dis Suppl; 1983; 127():129-36. PubMed ID: 6604645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucus and mucins.
    Rubin BK
    Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis. An overview.
    Ruzal-Shapiro C
    Radiol Clin North Am; 1998 Jan; 36(1):143-61. PubMed ID: 9465872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis.
    Rutland J; Cole PJ
    Thorax; 1981 Sep; 36(9):654-8. PubMed ID: 7314040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciliary function in health and disease.
    Greenstone M; Cole PJ
    Br J Dis Chest; 1985 Jan; 79(1):9-26. PubMed ID: 3885993
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mucociliary transport in obstructive lung disease].
    Lieberman D; Kieberman D
    Harefuah; 1987 Apr; 112(7):338-41. PubMed ID: 3305238
    [No Abstract]   [Full Text] [Related]  

  • 13. Phospholipid composition and surface-active properties of tracheobronchial secretions from patients with cystic fibrosis and chronic obstructive pulmonary diseases.
    Girod S; Galabert C; Lecuire A; Zahm JM; Puchelle E
    Pediatr Pulmonol; 1992 May; 13(1):22-7. PubMed ID: 1589308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).
    Shen Y; Huang S; Kang J; Lin J; Lai K; Sun Y; Xiao W; Yang L; Yao W; Cai S; Huang K; Wen F
    Int J Chron Obstruct Pulmon Dis; 2018; 13():399-407. PubMed ID: 29430174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucociliary transport and cough as clearance mechanisms in obstructive lung disease.
    Mossberg B; Camner P
    Eur J Respir Dis Suppl; 1980; 111():18-20. PubMed ID: 6938404
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis.
    Kellett F; Redfern J; Niven RM
    Respir Med; 2005 Jan; 99(1):27-31. PubMed ID: 15672845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucus and mucins in diseases of the intestinal and respiratory tracts.
    Hansson GC
    J Intern Med; 2019 May; 285(5):479-490. PubMed ID: 30963635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of mucociliary transport in the pathogenesis of chronic obstructive pulmonary disease.
    Yeates DB
    Adv Exp Med Biol; 1982; 144():411-5. PubMed ID: 7080936
    [No Abstract]   [Full Text] [Related]  

  • 19. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M; Dasgupta B; Tomkiewicz RP; Brown NE
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.